Covaxin
Latest news and video coverage curated from trusted media outlets
![Which is the Best Covid Vaccine? II Covishield vs Covaxin vs Sputnik-V II FAQs Covid 19 Vaccine [Video]](https://video.newsserve.net/300/v/20231213/1702499153-Which-is-the-Best-Covid-Vaccine-II-Covishield.jpg) Which is the Best Covid Vaccine? II Covishield vs Covaxin vs Sputnik-V II FAQs Covid 19 Vaccine Credit: Rumble Duration: 10:44Published | |
You Might Like
Biological E's Corbevax, Bharat Biotech's Covaxin get NTAGI's nod for use children aged 5-12 yearsPrime Minister Narendra Modi emphasised that all eligible children get the Covid-19 vaccine as soon as possible via "special programmes" in schools.DNA - Published | |
NTAGI approves Corbevax, Covaxin for 5-12 years age group: SourcesIndiaTimes - Published | |
NTAGI panel recommends use of Covid vaccines Corbevax, Covaxin for kids aged 5-12 yearsIndian Express - Published | |
Corbevax being considered as booster dose for Covishield, Covaxin jabbed peopleNTAGI is considering using Corbevax as a booster vaccination against Covid-19.DNA - Published | |
Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGIThe Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precaution dose for those aged 18 and above. India's first indigenously-developed RBD protein subunit vaccine, Corbevax, is..IndiaTimes - Published | |
Covaxin safe for 2-18 age group: BB studyIt conducted phase II/III, open-label, and multicentre study to evaluate the safety, reactogenicity and immunogenicity of Covaxin in children and adolescents in the 2-18 years of age group between..IndiaTimes - Published | |
Covaxin safe, immunogenic in children aged 2-18 years: LancetIndiaTimes - Published Also reported by •Indian Express | |
Covaxin booster beats back Delta, Omicron variants: NIVThe researchers compared the efficacy of Covaxin after the second and third doses against the Delta variant, and also studied its efficacy against the Omicron variants in a Syrian hamster model.IndiaTimes - Published Also reported by •Indian Express | |
Covaxin booster can protect against Omicron variants BA.1.1 and BA.2: ICMR studyIndian Express - Published | |
Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants: ICMR studyThe findings of the study by ICMR have been published on Tuesday on bioRxiv, a pre-print server and have not been peer-reviewed.DNA - Published Also reported by •Indian Express •IndiaTimes | |
33 districts wasted more Covaxin vials than Maharashtra average of 2.36%Indian Express - Published | |
NTAGI to discuss allowing Corbevax as booster shot for Covishield, Covaxin recipients: SourcesAllowing Biological E's Corbevax as a booster for those fully vaccinated against Covid-19 with either Covishield or Covaxin and reducing the gap between the second dose and the precaution dose of the..IndiaTimes - Published | |
Covaxin phase-3 trial concluded successfully at AMUnewKerala.com - Published | Germany approves Bharat Biotech's CovaxinnewKerala.com - Published |
Germany to recognize Bharat Biotech's COVAXIN for travel from June 1newKerala.com - Published | Covid-19 vaccine: Covaxin to be recognised by Germany for travel from June 1Covaxin was issued emergency use listing (EUL) by the World Health Organization (WHO) last November.DNA - Published |
BREAKING: Germany clears Bharat Biotech’s Covaxin, no vaccination proof required for fliers from June 1“Germany has approved Covaxin COVID19 vaccine. The entrants will no longer need proof of vaccination as the Federal Cabinet relaxes restrictions,” Bharat Biotech said on Twitter.Zee News - Published | FDA lifts hold on Covaxin's clinical trials in USThe US Food and Drug Administration which has put on hold the phase 2/ 3 clinical trials of Bharat Biotech's Covid-19 vaccine Covaxin, in USA, has lifted the pause, according to a statement issued by..IndiaTimes - Published |
Covaxin Phase 2&3 trials to resume in US after USFDA lifts clinical holdThe US Food and Drug Administration (USFDA) has lifted the clinical hold on the Phase 2 and 3 immuno-bridging clinical trials of Bharat Biotech’s Covid-19 vaccine Covaxin that were being conducted in..IndiaTimes - Published | Corbevax maker seeks emergency use approval as booster jab for adults vaccinated with Covishield, CovaxinThere were 416 patients aged 18 to 80 who got two doses of Covaxin or Covishield, the last one six months before the Corbevax booster.DNA - Published |
Bharat Biotech seeks approval for Covaxin booster trials for 2-18 age groupHyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population.Zee News - Published Also reported by •newKerala.com | Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-oldBharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI...IndiaTimes - Published |
Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SCnewKerala.com - Published | Bharat Biotech must address WHO’s Covaxin supply suspension to avoid EUL cancellation, says MEAIndian Express - Published Also reported by •IndiaTimes |
Covid-19: NRIs, Sputnik beneficiaries now unable to get boostersThousands of NRIs, who are back in India after taking Covid vaccines other than Covishield or Covaxin, now face a unique problem: they are unable to get the precaution doses.IndiaTimes - Published | Covaxin a universal vaccine: BB; 10cr doses with govt: Bio EIndiaTimes - Published |
DCGI gives emergency use authorisation to Covaxin for 6-12 age groupnewKerala.com - Published | DCGI approves COVID-19 vaccine Covaxin for children aged 6-12newKerala.com - Published |
Covaxin gets DCGI nod for 6-12 age group, Corbevax for 5-12 year oldsIndian Express - Published | BREAKING: DCGI gives emergency use nod to Covaxin for kids aged 6-12 amid fourth wave scareThe Drugs Controller General of India (DCGI) has given a restricted emergency use authorisation to Bharat Biotech's Covaxin for children aged 6-12 years, ANI news agency reported on Tuesday (April 26,..Zee News - Published |
DCGI gives approval for Bharat Biotech's Covaxin for children aged 6-12The Drug Controller General of India (DCGI) has given a restricted emergency use approval for Bharat Biotech's Covid-19 vaccine, Covaxin, for children between the age of six and 12. A Subject Expert..IndiaTimes - Published Also reported by •DNA | DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age groupThe Drug Controller General of India (DCGI) on Tuesday granted emergency use approval to Covid-19 vaccines, Covaxin and Corbevax, for children below 12. Bharat Biotech's Covaxin has got nod for use in..IndiaTimes - Published |
Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-oldsnewKerala.com - Published Also reported by •IndiaTimes | Expert panel of DCGI holds meet to discuss recommendations to use COVID-19 vaccines Corbevax, Covaxin for 5-12 age groupnewKerala.com - Published |
Fallout of WHO observations: Covaxin's Phase 2/3 trials in US put on holdThe US Food and Drug Administration has put on hold the phase 2/3 clinical trials of Bharat Biotech's Covid-19 vaccine Covaxin, in USA. Bharat Biotech's partner for US and Canada for Covaxin, the FDA's..IndiaTimes - Published | COVID vaccine: Covaxin price reduced from Rs 1,200 to Rs 225 per dose for private hospitalsnewKerala.com - Published |
Covid Update: Get Covaxin, Covishield at Rs 225Price slash of Covaxin and Covishield was announced after the government allowed all above 18 years of age can get booster dose from April 10.DNA - Published | Covid vaccines get big price cut! Covishield, Covaxin to be given at Rs 225 in private hospitalsVaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of the precaution dose of their respective COVID-19 vaccines to Rs 225 per shot for..Zee News - Published |
